Cardiology
News
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
Study shows empagliflozin led to a consistent, significant relative risk reduction compared with placebo in the primary endpoint.
News
Empagliflozin a winner in challenging arena of stabilized acute HF
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of...
Clinical
Early rhythm control in atrial fibrillation (EAST-AFNET trial)
Is rhythm control superior to rate control in treating early atrial fibrillation (AFib)?
News
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
News
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a...
News
EHRs have no impact on inpatient heart failure clinical choices or outcomes
Relative to usual care, prognostic information at the bedside provided no advantage for heart failure care.
Clinical
Troponin elevation at any age is a risk for cardiac mortality
Is an elevated troponin value associated with increased mortality, regardless of age?
News
BP Track: Blood pressure control rates dropped during pandemic
Data culled from 24 health systems showed lower rates of blood pressure control during the COVID-19 pandemic.
News
ASNC rejects new chest pain guideline it helped create
“We believe that the document fails to provide unbiased guidance to health care professionals on the optimal evaluation of patients with chest...
News
AHA/ACC issues first comprehensive guidance on chest pain
The clinical practice guideline offers a contemporary approach to determine which patients need further testing and which do not.